Various embodiments described herein relate generally to floss-like crystalline structures, including methods for producing floss-like crystalline structures.
It may be desirable to produce floss-like crystalline structures with coupled crystal structures.
In an embodiment, it may be desirable to produce floss-like crystalline structures with coupled crystal structures. In an embodiment, the floss-like crystalline structure (FLCS) may be formed from edible substances that may be formed into floss-like crystalline structures. Further, the edible substances may be formed into floss-like crystalline structures when heated to a melting point, extruded into floss-like threads, and cooled to the edible substance's crystallization point temperature.
In an embodiment, an edible substance may include various sugars and sugar alcohols. The sugars may include sucrose, glucose, fructose, or combinations thereof. The sugar alcohols may include arabitol, erythritol, glycerol, isomalt, lactitol, maltitol, mannitol, sorbitol, xylitol, sucrose, or combinations thereof. In an embodiment, the edible substance may include a combination of sugars and sugar alcohols. Any of these combinations when employed to form floss-like crystalline structures may be termed “cotton candy or fairy floss”. In an embodiment, any of these combinations may be heated to a melting point, extruded into floss-like threads, and cooled to the edible substance's crystallization point temperature to form floss-like crystalline structures (FLCS).
In an embodiment, other crystal or crystalline structures may be desirably coupled with the FLCS to provide other features and attributes to the FLCS. The other crystalline structures may include flavonoids, artificial flavors, medicants, or other structures that may desirably couple with the FLCS. In an embodiment, the crystal structure(s) (to be coupled) may have a lower melting or disassembly point than the crystal or crystalline material(s) that form the FLCS and may become part of the FLCS. In another embodiment, the crystal structure(s) (to be coupled with the FLCS) may have a smaller average particle size than the crystal or crystalline material(s) that form the FLCS and become adhered to the FLCS or become part of the FLCS as a function of their respective melting points.
In a further embodiment, the crystal structure(s) to be coupled may have a smaller average particle size and higher melting or disassembly point than the crystal material that forms the FLCS 12 and thus become adhered to the FLCS 12 as it is formed via melting or disassembly. As noted, in an embodiment, the crystal material(s) to be coupled to the FLCS 12 may include medicants. The medicants may include peptides, growth factors, and crystals or trichomes harvested or produced from cannabis plants or buds. The growth factors may be a naturally occurring substance capable of stimulating cellular growth. Crystals or trichomes harvested or produced from cannabis plants or buds may include one of the over 100 cannabinoids such as Tetrahydrocannabinol (THC), Cannabidiol (CBD), Cannabinol (CBN) crystals, or combinations of any of the over 100 cannabinoids.
In an embodiment, the product 10 may include sugar or sugar alcohol (or combinations thereof) based floss-like crystalline structures (FLCS) 12 with coupled crystal cannabinoids structures 14 according to various embodiments.
As shown in
As shown in
In an embodiment, the sugar, sugar alcohol or combinations thereof material 12 may have an average particle size greater than 250 to 500 microns and about 400-500 microns in an embodiment. In an embodiment, a floss generation machine may have ribbons or a spinner with openings that permit particles smaller than 250 microns to pass therethrough. In an embodiment, crystals 14 having nanometer sizes may be employed to be coupled with FLCS 12.
In an embodiment, the collected or produced cannabinoid crystals 14 may then be combined with sugar, sugar alcohol or combinations thereof material and other flavor and color elements to form a mixture (activities 48A, 48C) to be processed by a floss generation machine. In an embodiment, the mixture may include about 500 mg to 800 mg of cannabinoid crystals per 10 to 100 grams or about 28.3 grams (about an ounce) of sugar, sugar alcohol or combinations thereof material or about 1.7 to 2.8 percent cannabinoid crystals to sugar, sugar alcohol or combinations thereof material/crystals. In another, stronger embodiment, the mixture may include about 1000 mg to 1750 mg of cannabinoid crystals per 10 to 100 grams or about 28.3 grams of sugar, sugar alcohol or combinations thereof material or about 3.5 to 6.2 percent cannabinoid crystals to sugar, sugar alcohol or combinations thereof material/crystals.
Once the desired mixture is obtained, a floss generation machine may be employed to create the product 10 shown in
The resultant product 10 may be coupled to a cone 20A or stored in cylindrical container 20B in an embodiment. In general, any product 10 including floss-like crystalline structures 12 with adhered crystal structures 14 or including floss-like crystalline structures 12 melded with crystal structures 14 may formed via the algorithm 40B shown in
When the melting point or disassembly point of the crystals 14 is greater than the material used primarily to generate the flow-like structures 12 (activity 42B), the crystals 14 may be added directly to material 12 to form the mixture (activity 48B) when its particle size is less than the floss generation machine ribbon or spinner opening(s) (activity 44B). Otherwise, the crystals 14 to be adhered to the FLCS 12 may be granulated until its particle size is smaller than the floss generation machine ribbon or spinner opening(s) (activities 44B, 46B). In either case, the crystals 14 (or granulated crystals) may be added to the main material 12 to form a mixture (activity 48B). A floss generation machine may then be employed to produce the product 10 with FLCS 12 and adhered crystals structures 14.
The accompanying drawings that form a part hereof show, by way of illustration and not of limitation, specific embodiments in which the subject matter may be practiced. The embodiments illustrated are described in sufficient detail to enable those skilled in the art to practice the teachings disclosed herein. Other embodiments may be utilized and derived therefrom, such that structural and logical substitutions and changes may be made without departing from the scope of this disclosure. This Detailed Description, therefore, is not to be taken in a limiting sense, and the scope of various embodiments is defined only by the appended claims, along with the full range of equivalents to which such claims are entitled.
Such embodiments of the inventive subject matter may be referred to herein individually or collectively by the term “invention” merely for convenience and without intending to voluntarily limit the scope of this application to any single invention or inventive concept, if more than one is in fact disclosed. Thus, although specific embodiments have been illustrated and described herein, any arrangement calculated to achieve the same purpose may be substituted for the specific embodiments shown. This disclosure is intended to cover any and all adaptations or variations of various embodiments. Combinations of the above embodiments, and other embodiments not specifically described herein, will be apparent to those of skill in the art upon reviewing the above description.
The Abstract of the Disclosure is provided to comply with 37 C.F.R. § 1.72(b), requiring an abstract that will allow the reader to quickly ascertain the nature of the technical disclosure. It is submitted with the understanding that it will not be used to interpret or limit the scope or meaning of the claims. In the foregoing Detailed Description, various features are grouped together in a single embodiment for the purpose of streamlining the disclosure. This method of disclosure is not to be interpreted to require more features than are expressly recited in each claim. Rather, inventive subject matter may be found in less than all features of a single disclosed embodiment. Thus the following claims are hereby incorporated into the Detailed Description, with each claim standing on its own as a separate embodiment.
Number | Date | Country | |
---|---|---|---|
62515446 | Jun 2017 | US |